2Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis:the bath ankylosing spondylitis disease activity index.J Rheumatol,1994,21(12):2286-2291.
3Critchlow MA, Bland YS. The effect of exogenous Transforming growth factor-beta 2 on healing fractures in the rabbit.Bone,1995,16(5):521.
4陈灏珠.实用内科学[M].11版.北京:人民卫生出版社,2001:2325-2327.
5CALIN A,ELSWOOD J,RIGG S,et al.Ankylosing spondylitis:an analytical review of 1 500 patients of the disease[J].J Rheumatol,1988,15(8):1234-1238.
6KHAN M.A current perspective on ankylosing spondylitis and related spondyloarthropathies[J].J Ind Rheum Asso,1999,7(1):16-22.
7AMOR B,DOUGADOS M,MIJIYAMA H.Criterin of the classification of spondylarthropathies[J].Rev Rheum Mal Osteoartic,1990,57(2):85-89.
8Corrigal V,Panayi GS,Unger A,et al.Detection of immue complexes in serum of Patient with anklosig spondylitis.Rheum D,1998,37:59
9Clegg DO,Reda DJ,Abdellatif M.Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of seronegative spodylarthropathies.Arthritis Rheum,1999,42:2325 ～ 2329.
